SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Beryl Drugs informs about outcome of board meeting

11 Jul 2016 Evaluate

Beryl Drugs has informed that the Board of the Directors of the Company at its meeting held on July 11, 2016, has considered and approved the Directors Report for the financial year ended on March 31, 2016; Book Closure Notice and fixed the cut -off date for entitlement of Voting Rights of Member for remote E-Voting; 23rd Annual General Meeting Notice and directed to dispatch the Notice to the Shareholders; authorized Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

25.46 0.94 (3.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×